← All companies
GPAT
GP-Act III Acquisition Corp.
$11.15
+0.23 +2.11%
Key statistics
from XBRL data in SEC filingsMarket cap
$69.7M
Revenue (TTM)
—
Net income (TTM)
$11.1M
EPS (TTM)
—
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$119K
Total assets
$312M
Gross margin
—
52-week range
$10.50 – $12.00
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-03-31
May 14, 2026
8-K
Entered a material agreement; Amended charter or bylaws; Shareholder vote results
May 14, 2026
8-K
Entered a material agreement
May 13, 2026
8-K
Other events
May 7, 2026
8-K
Shareholder vote results
May 6, 2026
8-K
Other events
May 5, 2026
8-K
Shareholder vote results
Apr 29, 2026
10-K
Fiscal year ended 2025-12-31
Mar 26, 2026
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
10-Q
Quarter ended 2025-06-30
Aug 13, 2025
10-Q
Quarter ended 2025-03-31
May 14, 2025
10-K
Fiscal year ended 2024-12-31
Mar 28, 2025
10-Q
Quarter ended 2024-09-30
Nov 13, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
8-K
Other events
Jun 28, 2024
10-Q
Quarter ended 2024-03-31
Jun 21, 2024
8-K
Other events
May 17, 2024
8-K
Other events
May 14, 2024
Other filings
SCHEDULE 13G/A
Jun 5, 2026
SCHEDULE 13G
Jun 4, 2026
425
CURRENT REPORT
May 14, 2026
DEFA14A
DEFINITIVE ADDITIONAL MATERIALS
May 6, 2026
DEFA14A
DEFINITIVE ADDITIONAL MATERIALS
Apr 29, 2026
SCHEDULE 13G/A
Apr 27, 2026
DEF 14A
PROXY STATEMENT
Mar 30, 2026
PRE 14A
PROXY STATEMENT
Mar 19, 2026
SCHEDULE 13G/A
Feb 12, 2026
SCHEDULE 13G
Nov 13, 2025
SCHEDULE 13G/A
Aug 14, 2025
SCHEDULE 13G/A
Aug 14, 2025
SCHEDULE 13G
Aug 14, 2025
SCHEDULE 13G/A
Aug 12, 2025
SCHEDULE 13G/A
May 13, 2025
SCHEDULE 13G/A
Mar 28, 2025
SCHEDULE 13G
Mar 7, 2025
SCHEDULE 13G/A
Feb 14, 2025
SCHEDULE 13G
Feb 14, 2025
SCHEDULE 13G/A
Feb 10, 2025
SC 13G
13G GPATU
Nov 14, 2024
SC 13G
Nov 14, 2024